159 related articles for article (PubMed ID: 26722593)
1. Acute myeloid leukemia of a primary hepatic carcinoma patient after liver transplantation: a case report and literature review.
Wu WJ; Dong MM; Chen Y; He JS; Huang H; Cai Z
Int J Clin Exp Pathol; 2015; 8(10):13655-60. PubMed ID: 26722593
[TBL] [Abstract][Full Text] [Related]
2. Acute myeloid leukemia following solid organ transplantation: case report and comprehensive review.
Kourelis TV; Boruchov A; Hull D; Polio J; Scholes J; Moustakakis M; Bilgrami SF
Conn Med; 2012 Mar; 76(3):151-4. PubMed ID: 22666974
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors affecting survival at recurrence of hepatocellular carcinoma after living-donor liver transplantation: with special reference to neutrophil/lymphocyte ratio.
Harimoto N; Shirabe K; Nakagawara H; Toshima T; Yamashita Y; Ikegami T; Yoshizumi T; Soejima Y; Ikeda T; Maehara Y
Transplantation; 2013 Dec; 96(11):1008-12. PubMed ID: 24113512
[TBL] [Abstract][Full Text] [Related]
4. Hepatic venous congestion in living donor grafts in liver transplantation: is there an effect on hepatocellular carcinoma recurrence?
Suh SW; Lee JM; You T; Choi YR; Yi NJ; Lee KW; Suh KS
Liver Transpl; 2014 Jul; 20(7):784-90. PubMed ID: 24668935
[TBL] [Abstract][Full Text] [Related]
5. Younger age and presence of macrovascular invasion were independent significant factors associated with poor disease-free survival in hepatocellular carcinoma patients undergoing living donor liver transplantation.
Wai CT; Woon WA; Tan YM; Lee KH; Tan KC
Transplant Proc; 2012 Mar; 44(2):516-9. PubMed ID: 22410059
[TBL] [Abstract][Full Text] [Related]
6. Living donor liver transplantation for hepatocellular carcinoma.
Isik B; Ince V; Karabulut K; Kayaalp C; Yilmaz S
Transplant Proc; 2012; 44(6):1713-6. PubMed ID: 22841251
[TBL] [Abstract][Full Text] [Related]
7. Effects of loco regional treatments before living donor liver transplantation on overall survival and recurrence-free survival in South Korean patients with hepatocellular carcinoma.
Na GH; Kim EY; Hong TH; You YK; Kim DG
HPB (Oxford); 2016 Jan; 18(1):98-106. PubMed ID: 26776857
[TBL] [Abstract][Full Text] [Related]
8. Section 5. Further expanding the criteria for HCC in living donor liver transplantation: when not to transplant: SNUH experience.
Lee KW; Yi NJ; Suh KS
Transplantation; 2014 Apr; 97 Suppl 8():S20-3. PubMed ID: 24849825
[TBL] [Abstract][Full Text] [Related]
9. Predictive Value of Alpha-fetoprotein in the Survival of Living Donor Liver Transplantation Recipients for Hepatocellular Carcinoma.
Jiang L; Liao A; Yan L; Li B; Zhu W; Wen T
Hepatogastroenterology; 2014 May; 61(131):747-51. PubMed ID: 26176068
[TBL] [Abstract][Full Text] [Related]
10. A case of gastric cancer following living donor liver transplantation.
Takehara H; Tanabe K; Fujikuni N; Tahara H; Ide K; Tanaka Y; Yasui W; Ohdan H
Hiroshima J Med Sci; 2014 Sep; 63(1-3):23-6. PubMed ID: 25735064
[TBL] [Abstract][Full Text] [Related]
11. Long-term recurrence-free survival after liver transplantation from an ABO-incompatible living donor for treatment of hepatocellular carcinoma exceeding Milano criteria in a patient with hepatitis B virus cirrhosis: a case report.
Nakamura Y; Hama K; Iwamoto H; Yokoyama T; Kihara Y; Konno O; Jojima Y; Shimazu M
Transplant Proc; 2012 Mar; 44(2):565-9. PubMed ID: 22410070
[TBL] [Abstract][Full Text] [Related]
12. Early occurrence of hepatocellular carcinoma in biliary atresia treated by liver transplantation.
Brunati A; Feruzi Z; Sokal E; Smets F; Fervaille C; Gosseye S; Clapuyt P; de Ville de Goyet J; Reding R
Pediatr Transplant; 2007 Feb; 11(1):117-9. PubMed ID: 17239135
[TBL] [Abstract][Full Text] [Related]
13. Investigation of histological vascular invasion from preoperative evaluation in patients with hepatocellular carcinoma who underwent living donor liver transplantation.
Sakai K; Okajima H; Koshino K; Suzuki T; Nobori S; Matsuyama M; Ushigome H; Ochiai T; Yoshimura N
Transplant Proc; 2012 Mar; 44(2):409-11. PubMed ID: 22410029
[TBL] [Abstract][Full Text] [Related]
14. Living-donor liver transplantation for hepatocellular carcinoma.
Kaihara S; Kiuchi T; Ueda M; Oike F; Fujimoto Y; Ogawa K; Kozaki K; Tanaka K
Transplantation; 2003 Feb; 75(3 Suppl):S37-40. PubMed ID: 12589138
[TBL] [Abstract][Full Text] [Related]
15. Liver transplant for hepatocellular carcinoma: experience in a Saudi population.
Allam N; Khalaf H; Fagih M; Al-Sebayel M
Exp Clin Transplant; 2008 Mar; 6(1):14-24. PubMed ID: 18405240
[TBL] [Abstract][Full Text] [Related]
16. Primary versus salvage living donor liver transplantation for patients with hepatocellular carcinoma: impact of microvascular invasion on survival.
Moon JI; Kwon CH; Joh JW; Choi GS; Jung GO; Kim JM; Shin M; Choi SJ; Kim SJ; Lee SK
Transplant Proc; 2012 Mar; 44(2):487-93. PubMed ID: 22410053
[TBL] [Abstract][Full Text] [Related]
17. Chronic myeloid leukemia after living donor liver transplantation.
Concejero A; Chen CL; Wang CC; Wang SH; Lin CC; Liu YW; Yang CH; Yong CC; Wang MC; Eng HL
Transplantation; 2007 Jun; 83(11):1521-2. PubMed ID: 17565329
[No Abstract] [Full Text] [Related]
18. Local therapy improvement of outcome in a patient with recurrent hepatocellular carcinoma after living donor liver transplantation: a case report.
Shimokawa M; Itoh S; Ikegami T; Takeishi K; Harimoto N; Yamashita YI; Yoshizumi T; Kawanaka H; Shirabe K; Maehara Y
Anticancer Res; 2015 Jun; 35(6):3525-9. PubMed ID: 26026120
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the outcomes of patients who underwent deceased-donor or living-donor liver transplantation after successful downstaging therapy.
Lei J; Yan L; Wang W
Eur J Gastroenterol Hepatol; 2013 Nov; 25(11):1340-6. PubMed ID: 23652915
[TBL] [Abstract][Full Text] [Related]
20. Liver transplantation for adult patients with hepatocellular carcinoma in Korea: comparison between cadaveric donor and living donor liver transplantations.
Hwang S; Lee SG; Joh JW; Suh KS; Kim DG
Liver Transpl; 2005 Oct; 11(10):1265-72. PubMed ID: 16184545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
